Latest Articles
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study - Yahoo Finance
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study Yahoo Finance
Published: May 19, 2026, 3:47 p.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times
Published: May 19, 2026, 3:15 p.m.
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer - TradingView
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer TradingView
Published: May 19, 2026, 2 p.m.
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace
Published: May 19, 2026, 11:19 a.m.
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer - Indian Pharma Post
Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer Indian Pharma Post
Published: May 19, 2026, 9:08 a.m.
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ - Chosunbiz
Merck-Kelun ADC boosts survival in phase 3 endometrial cancer, stokes TROP2 race - CHOSUNBIZ Chosunbiz
Published: May 19, 2026, 6:54 a.m.
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri - GuruFocus
Merck's Sac-TMT Shows Promise in Advanced Endometrial Cancer Tri GuruFocus
Published: May 18, 2026, 11:38 p.m.
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T - GuruFocus
Merck (MRK) Achieves Milestone in Endometrial Cancer Treatment T GuruFocus
Published: May 18, 2026, 10:39 p.m.
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer - CancerNetwork
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer CancerNetwork
Published: May 18, 2026, 7:33 p.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - Yahoo
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial Yahoo
Published: May 18, 2026, 4:44 p.m.
Link copied to clipboard!